An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation

Ketty Sinigaglia1, Anna Cherian1, Qiupei Du1

  • 1Central European Institute for Technology at Masaryk University (CEITEC MU), Building E35, Kamenice 735/5, 625 00 Brno, Czechia; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czechia.

Cell Reports
|August 15, 2024
PubMed

Insights

Adenosine deaminase acting on RNA 1 (ADAR1) inhibits Protein Kinase R (PKR) activation, preventing embryonic lethality in mice. This interaction is crucial for maintaining intestinal integrity and long-term survival by regulating interferon responses.

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • Aberrant interferon induction leads to embryonic lethality in Adar null mutant mice.
  • Mice lacking both Adar and Mavs exhibit early postnatal lethality, with intestinal damage linked to Protein Kinase R (PKR) activation.

Purpose of the Study:

  • To investigate the protective role of Adenosine deaminase acting on RNA 1 (ADAR1) against PKR-mediated lethality.
  • To elucidate the molecular mechanism of ADAR1-mediated PKR inhibition.

Main Methods:

  • Generation and analysis of Adar, Mavs, and Eifak2 (PKR) mutant mouse models.
  • Co-immunoprecipitation assays to detect protein interactions.
  • AlphaFold structural modeling to predict binding interfaces.
  • In vitro experiments using human ADAR1 in A549 cells to assess PKR activation.

Main Results:

  • Triple mutant mice (Adar Mavs Eifak2) show rescued lethality and intestinal defects, indicating PKR's central role.
  • ADAR1 and PKR co-immunoprecipitate, suggesting a direct interaction.
  • Structural modeling proposes an inhibitory interaction between ADAR1's dsRBD3 and PKR's kinase domain.
  • ADAR1 expression inhibits endogenous PKR activation in human cells, dependent on dsRNA binding and a specific ADAR1-PKR contact.

Conclusions:

  • ADAR1 directly interacts with and inhibits PKR activation, preventing lethal interferon responses.
  • The interaction requires ADAR1 dsRNA binding and a specific contact interface involving ADAR1 dsRBD3.
  • This mechanism highlights ADAR1's critical role in innate immunity and preventing PKR-driven pathology.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K